Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by MuffleR

T.VRN

RE:RE:RE:RE:CPG Financials

it wouldnt be that high. in my analysis ~75% would go to ncib and 25~ to...

October 24, 2022

T.VRN

RE:RE:CPG Financials

my opinion in CAD revenue: ~1100 $ opec + roy+tran+g&a+ interest :~ 420 ...

October 24, 2022

T.VRN

RE:RE:RE:Q3 hedges 56% of production @75.00 cad floor price

look between the line - until now half of the hedges were swaps (appx) look...

September 7, 2018

T.VRN

RE:CPG = Lightstream

i see your feer for it, but i think its not the same.  from the web i...

September 6, 2018

T.VRN

you had one like him -

and hes been fired. thanks god.

August 9, 2018

Featured Company

NurExone Biologic Inc.

NurExone Biologic Inc. V.NRX

NurExone Biologic Inc. is a biopharmaceutical company. The Company is developing and commercializing an exosome therapy ... view more »